辛伐他汀联合缬沙坦治疗高血压伴高脂血症临床分析.docxVIP

辛伐他汀联合绷沙坦治疗高血压伴高脂血症临床分析四川省凉山州第一人民医院心内科四川凉山615000 摘要目的观察分析辛伐他汀联合绷沙坦治疗高血压伴高脂血症的临床应用效果。方法木次研究行回顾性调查法，以我院98例高血压伴高脂血症患者为对象实施研究方案。随机法分组，均分至对照、试验两组，对照组患者服用氨氯地平阿托伐他汀，试验组患者服用辛伐他汀联合颂沙坦，对比记录两组的应用效果。结果①治疗后，两组血压与血脂水平均有所改善，但试验组改善程度优于对照组，具有统计学差异(PC0.05)；②试验组血压控制结局总有效率为95.9%(47/49), 对照组为77.6% (38/49),优势明显，具有统计学差异(P0.05)o结论对于高血压伴高脂血症患者而言，辛伐他汀联合纟颉沙坦能明显降低患者的体内血压与血脂水平，有效控制疾病进一步发展，改善预后情况，值得临床应用借鉴。关键词高血压；高脂血症；辛伐他汀；颂沙坦【中图分类号】R963【文献标识码】A【文章编号】1001-5213(2016)09-0269-02 The Clinical analysis of simvastatin combined with valsartan in the treatment of hypertension complicated with hyperlipidemia[Abstract] Objective To observe and analyze the simvastatin combined with valsartan in the treatment of hypertension with hyperlipidemia clinical effect. Methods the retrospective survey method, to our hospital 98 cases of hypertension with hyperlipemia patients as the object of study of the implementation of the scheme. Were randomly, divided into control and experimental groups, control group patients taking amlodipine and atorvastatin of atorvastatin, test group patients taking simvastatin and valsartan, record for comparison of application effect of the two groups. Results (1) after treatment, two groups of blood pressure and blood lipid level were improved, but the experimental group improved better than the contrast group, with significant differenee (P lt; 0.05); in the test group, the blood pressure Control outcomes the total efficiency was 95.9% (47 / 49), control group was 77.6% (38 / 49), the advantage is obvious, with significant difference (P lt; 0.05).Conclusion for hypertension and hyperlipidemia patients, simvastatin and valsartan can sigrdficantly decreased in parents with blood pressure and blood lipids in vivo, effectively control the further developme nt of the disease, improve the prog no sis, it is worth clin ical application of ref ere nee.[Keywords] hypertension; hyperlipidemia; simvastatin; valsartan随着社会的现代化改变，生活节奏的加快、饮食结构的富裕化、人际关系的紧张化等无形因素都使心血管疾病的发病率日益增加[1]。高血压与高脂血症均为其基础性疾病。高血